Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C37H45F3N6O5 |
| Molecular Weight | 710.7856 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC(OC)=C1CN2CC[C@H](N3CCN(CC3)C4=CC=C(N[C@H]5CCC(=O)NC5=O)C=C4F)C(F)(F)C2)C6=CN(C)C(=O)C(C)=C6C
InChI
InChIKey=GNRGNRCQXHMQQV-ZQAZVOLISA-N
InChI=1S/C37H45F3N6O5/c1-22-23(2)36(49)43(3)19-26(22)24-16-31(50-4)27(32(17-24)51-5)20-44-11-10-33(37(39,40)21-44)46-14-12-45(13-15-46)30-8-6-25(18-28(30)38)41-29-7-9-34(47)42-35(29)48/h6,8,16-19,29,33,41H,7,9-15,20-21H2,1-5H3,(H,42,47,48)/t29-,33-/m0/s1
| Molecular Formula | C37H45F3N6O5 |
| Molecular Weight | 710.7856 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 12:24:04 GMT 2025
by
admin
on
Wed Apr 02 12:24:04 GMT 2025
|
| Record UNII |
AW8PEP3VZ3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
865121
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C187693
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY | |||
|
AW8PEP3VZ3
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY | |||
|
163203607
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY | |||
|
300000049356
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY | |||
|
12940
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY | |||
|
2704617-96-7
Created by
admin on Wed Apr 02 12:24:04 GMT 2025 , Edited by admin on Wed Apr 02 12:24:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->DEGRADER |
PRECLINICAL
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
CFT8634 is a novel Bifunctional Degradation Activating Compound Degrader, also known as a BiDAC™ degrader, of bromodomain-containing protein 9 (BRD9). CFT8634 is comprised of
ligand binding moieties for BRD9 and the cereblon (CRBN) E3 ligase. CRBN facilitates E3 ligasecatalyzed ubiquitination of BRD9. Following polyubiquitination, BRD9 is then degraded by the cellular proteasome.
|